Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Nasopharyngeal carcinoma, 607107 (Nasopharyngeal carcinoma) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Nasopharyngeal carcinoma, 607107 (Nasopharyngeal carcinoma) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
GALNT3 Gene Tumoral calcinosis, hyperphosphatemic, familial, type 1 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 59 | 16 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
Centogene AG - the Rare Disease Company Germany | 12 | 1 |
|
TP53 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 12 | 1 |
|
Invitae Multi-Cancer + RNA Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 142 | 63 |
|
Invitae Common Hereditary Cancers + RNA Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 114 | 47 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 59 | 16 |
|
Genome-Nilou Lab Iran | 45 | 34 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 754 | 562 |
|
Invitae Hereditary Lymphoma Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 85 | 43 |
|
Ambry Genetics United States | 79 | 37 |
|
Variant Resolution Test for CancerNext® 37 (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Variant Resolution Test for Penn Cancer Grant Panel (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Ambry Genetics United States | 79 | 80 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 249 | 155 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.